enGene Therapeutics Inc (ENGN)

Last Closing Price: 1.82 (2026-07-17)

Receiveable Turnover (Quarterly)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

enGene Therapeutics Inc (ENGN) Receiveable Turnover data is not available.

Figures for fiscal quarter ending 2026-04-30
Income Statement Financials
--
$-30.23M
--
--
$31.97M
$-31.97M
$1.74M
$-30.23M
$-30.23M
$-30.23M
$-30.23M
$-30.23M
$-30.23M
$-31.97M
$-32.28M
69.72M
69.72M
$-0.43
$-0.43
Balance Sheet Financials
$270.00M
$2.33M
$37.52M
$307.52M
$21.48M
$24.91M
$30.87M
$52.36M
$255.17M
$255.17M
$255.17M
66.99M
Cash Flow Statement Financials
$-59.40M
$-102.66M
$141.73M
$50.15M
$29.83M
$-20.32M
$6.95M
--
--
Fundamental Metrics & Ratios
12.57
--
--
0.09
0.10
--
--
--
--
--
--
$-59.65M
--
--
--
--
--
Receiveable Turnover
--
--
-11.85%
-11.85%
-9.83%
-10.79%
$3.81
$-0.86
$-0.85